Risk Factors and Outcomes for Isolation with Polymyxin B-Resistant Enterobacterales from 2018-2022: A Case-Control

Wenjuan Yan1, Jiaojiao Wu2, Shanmei Wang1

  • 1Department of Clinical Microbiology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, Henan, People's Republic of China.

PubMed
Abstract

Insights

Polymyxin B-resistant Enterobacterales infections are linked to chronic heart disease, immunosuppression, drainage tubes, and prior polymyxin B exposure. These resistant strains predict unfavorable outcomes, highlighting the need for monitoring their spread.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Antimicrobial Resistance

Background:

  • The emergence of polymyxin B-resistant (PR) Enterobacterales poses a significant threat to public health.
  • Understanding the risk factors and clinical outcomes associated with PR Enterobacterales is crucial for effective infection control.
  • Enterobacterales are a common cause of hospital-acquired infections, and resistance to last-resort antibiotics like polymyxin B is a growing concern.

Purpose of the Study:

  • To identify risk factors associated with the isolation of polymyxin B-resistant (PR) Enterobacterales from clinical specimens.
  • To analyze the clinical outcomes of patients infected with PR Enterobacterales.
  • To provide data for the prevention and control of the spread of PR Enterobacterales strains.

Main Methods:

  • A retrospective case-control study was conducted from 2018 to 2022.
  • 72 patients with PR Enterobacterales isolates (cases) were compared with 144 patients with polymyxin B-susceptible (PS) Enterobacterales isolates (controls).
  • Data on patient demographics, clinical characteristics, and laboratory records were collected and analyzed using bivariable logistic regression and Pearson's chi-square tests.

Main Results:

  • Predominant PR strains were Klebsiella pneumoniae (72.2%) and Salmonella enteritidis (8.3%).
  • Significant risk factors for PR Enterobacterales isolation included chronic heart disease, immunosuppressant use, drainage tube placement, and prior polymyxin B exposure.
  • Treatment failure was more frequent in patients with PR strains (45.83%) compared to controls (14.58%), and was associated with ICU admission, hypertension, and drainage tube use.

Conclusions:

  • Chronic heart disease, immunosuppression, drainage tubes, and polymyxin B exposure are key risk factors for PR Enterobacterales isolation.
  • Isolation of PR Enterobacterales is a significant predictor of unfavorable clinical outcomes, including treatment failure.
  • These findings underscore the importance of monitoring the prevalence and spread of PR Enterobacterales to guide antimicrobial stewardship and infection control strategies.